Kineta

2 followers

Kineta aims at developing edge therapeutics in autoimmune disease, viral disease, and chronic pain areas.

Employees

11-50

Links


Org chart

Thu le
Controller
Kurt Lustig
Director, Translational Development

Board & advisors